X

pharmaceuticals

Unichem Laboratories Ltd Q1FY24; 37% rise in Revenue

Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd…

Biocon Ltd.: Driving Growth in Pharmaceutical Industry.

Stock Data: TickerNSE: BIOCONExchangeNSEIndustryPHARMACEUTICALS Price Performance: Last 5 Days+1.43%YTD-7.18%Last 12 Months-22.16%As on 16-06-2023 Company Description: Biocon is India's premier biotechnology…

Venus Remedies Ltd Q4FY23 results out, revenue grows by over 10%

Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged…

Alphagraph | Aurobindo Pharma Ltd (NSE: AUROPHARMA): Q4FY23 Results Out; Total Income rises 13% YoY.

Aurobindo Pharma is a leading pharmaceutical company primarily involved in the manufacturing and marketing of active pharmaceutical ingredients (APIs), generic…

Alphagraph | Brooks Laboratories Ltd (NSE: BROOKS): Q4FY23 Results Out; Total Income fell 56% YoY.

Brooks Laboratories Ltd is a pharmaceutical manufacturing company that primarily operates on a contract basis. The company specializes in the…

Earnings Summary Of FDC Limited For Q4 FY23

FDC Limited is a renowned Indian pharmaceutical company that has been in operation for over 85 years. Founded in 1936,…

AMI Organics Ltd (AMIORG) Q4 FY23 Earnings Concall Transcript

AMI Organics Ltd (NSE:AMIORG) Q4 FY23 Earnings Concall dated May. 15, 2023. Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Ramjibhai…

Earnings | Albert David Ltd (NSE: ALBERTDAVD): Q4FY23 Results Out; Total Income rises 9% YoY.

Albert David Ltd is a pharmaceutical company involved in both manufacturing and trading activities. The company focuses on the production…

Torrent Pharmaceuticals Ltd Q4FY23 revenue grows by 17%

Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting…

Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY23 Earnings Concall Transcript

Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q4 FY23 Earnings Concall dated May. 30, 2023 Corporate Participants: Sudhir Menon — Executive Director, (Finance) and…